Kiernan A. Seth
Plus aucun poste en cours
Fortune : 127 526 $ au 31/03/2024
Profil
Kiernan A.
Seth worked as the Head of the Oncology Business Unit at Eisai, Inc. He then served as the Chief Commercial Officer & Vice President at Lexicon Pharmaceuticals, Inc. from 2021 to 2023.
Dr. Seth completed his undergraduate degree at Norfolk State University, followed by an MBA from St. Joseph's University.
He also obtained a doctorate from Meharry Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2023 | 53 136 ( 0,02% ) | 127 526 $ | 31/03/2024 |
Anciens postes connus de Kiernan A. Seth
| Sociétés | Poste | Fin |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/11/2023 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | - |
Formation de Kiernan A. Seth
| Norfolk State University | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
| Meharry Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
